Studies on protein metabolism during isoproterenol-induced cardiac hypertrophy. 1975

Y Deshaies, and J LeBlanc, and J Willemot

Chronic treatment with isoproterenol (ISO) (30 mug/100 g body wt/day for 21 days) causes a hypertrophy of the heart (approximately 40%). Protein determination made on homogenates of the heart show similar percentages of protein in the control and treated animals. Thus, ISO presumably stimulates protein synthesis in the heart, as its total protein content is increased by chronic treatment. Studies of the stimulation of protein synthesis during a 9-day treatment with ISO have been carried out by following the incorporation of 14C-labeled amino acids in vivo into heart protein. This stimulation attained a maximum after 5 days of treatment and then declined. In other experiments, groups of rats received a single injection of ISO and were killed at various times (from 0 to 48 hr) after the injection. Stimulation of protein synthesis was maximal 3 hr after the injection, and it slowly decreased until the 36th hr. After that time the rate of protein synthesis was equal to that of control animals. Other groups of rats received daily injections of ISO for 9 days and were killed at various times after the ninth injection. Protein synthesis was still stimulated by ISO; however, the stimulation was observed only during the first 12 hr following the injection of the 9th day. There was an apparent inhibition of protein synthesis which lasted from the 30th to the 48th hr following the ninth injection. The rate of protein degradation did not seem to be affected by a chronic treatment with ISO. Thus, the increased rate of protein synthesis seems to be the sole factor responsible for the increase of the total protein content of the heart, even if the stimulation of the incorporation of labeled amino acids decreased after a few days of treatment.

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D006332 Cardiomegaly Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. Cardiac Hypertrophy,Enlarged Heart,Heart Hypertrophy,Heart Enlargement,Cardiac Hypertrophies,Enlargement, Heart,Heart Hypertrophies,Heart, Enlarged,Hypertrophies, Cardiac,Hypertrophies, Heart,Hypertrophy, Cardiac,Hypertrophy, Heart
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Y Deshaies, and J LeBlanc, and J Willemot
January 1978, Acta biochimica et biophysica; Academiae Scientiarum Hungaricae,
Y Deshaies, and J LeBlanc, and J Willemot
November 1966, Japanese heart journal,
Y Deshaies, and J LeBlanc, and J Willemot
January 1977, Acta biologica Academiae Scientiarum Hungaricae,
Y Deshaies, and J LeBlanc, and J Willemot
September 1984, Canadian journal of physiology and pharmacology,
Y Deshaies, and J LeBlanc, and J Willemot
April 1984, Canadian journal of physiology and pharmacology,
Y Deshaies, and J LeBlanc, and J Willemot
November 2008, Drug metabolism and disposition: the biological fate of chemicals,
Y Deshaies, and J LeBlanc, and J Willemot
May 2016, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Y Deshaies, and J LeBlanc, and J Willemot
January 1995, Romanian journal of physiology : physiological sciences,
Y Deshaies, and J LeBlanc, and J Willemot
December 1976, Biochemical and biophysical research communications,
Y Deshaies, and J LeBlanc, and J Willemot
January 1990, The American journal of cardiovascular pathology,
Copied contents to your clipboard!